Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Stewart

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Clinical Chemistry|December 4, 2018
Cardiovascular Disease and Frailty: What Are the Mechanistic Links?Ralph Stewart
Heart (British Cardiac Society)|February 7, 2015
Do risk factors for cardiovascular disease also increase the risk of frailty?Ralph Stewart
Heart, Lung & Circulation|June 22, 2014
Bias in the evaluation of effects of statins on mortality in patients with heart failureJonathon White, Ralph Stewart
The New Zealand Medical Journal|September 30, 2020
Computers, confounding, clusters, consent, cost, COVID and consultation: how the Health and Disability Code impedes the learning health systemMark Webster, Ralph Stewart
Heart (British Cardiac Society)|May 2, 2023
Should beta-blockers be recommended after myocardial infarction when left ventricular ejection fraction is normal?Tom Evans, Ralph Stewart
Clinical Medicine Insights. Cardiology|July 31, 2012
Safety and efficacy of apixaban in the treatment of atrial fibrillationAndrew Martin, Ralph Stewart
The New Zealand Medical Journal|January 29, 2003
Inflammation, atherosclerosis and predicting cardiovascular riskMichael Williams, Ralph Stewart
Expert Review of Cardiovascular Therapy|September 22, 2011
Medical treatment of asymptomatic chronic aortic regurgitationAaron Lin, Ralph Stewart
Circulation|January 15, 2016
Increasing Evidence for an Association Between Periodontitis and Cardiovascular DiseaseRalph Stewart, Malcolm West
The New Zealand Medical Journal|August 24, 2022
The unexpected benefits of sodium glucose co-transporter 2 (SGLT2) InhibitorsChok G Chan, Ralph Stewart
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Clinical Chemistry|December 4, 2018
Cardiovascular Disease and Frailty: What Are the Mechanistic Links?Ralph Stewart
Heart (British Cardiac Society)|February 7, 2015
Do risk factors for cardiovascular disease also increase the risk of frailty?Ralph Stewart
Heart, Lung & Circulation|June 22, 2014
Bias in the evaluation of effects of statins on mortality in patients with heart failureJonathon White, Ralph Stewart
The New Zealand Medical Journal|September 30, 2020
Computers, confounding, clusters, consent, cost, COVID and consultation: how the Health and Disability Code impedes the learning health systemMark Webster, Ralph Stewart
Heart (British Cardiac Society)|May 2, 2023
Should beta-blockers be recommended after myocardial infarction when left ventricular ejection fraction is normal?Tom Evans, Ralph Stewart
Clinical Medicine Insights. Cardiology|July 31, 2012
Safety and efficacy of apixaban in the treatment of atrial fibrillationAndrew Martin, Ralph Stewart
The New Zealand Medical Journal|January 29, 2003
Inflammation, atherosclerosis and predicting cardiovascular riskMichael Williams, Ralph Stewart
Expert Review of Cardiovascular Therapy|September 22, 2011
Medical treatment of asymptomatic chronic aortic regurgitationAaron Lin, Ralph Stewart
Circulation|January 15, 2016
Increasing Evidence for an Association Between Periodontitis and Cardiovascular DiseaseRalph Stewart, Malcolm West
The New Zealand Medical Journal|August 24, 2022
The unexpected benefits of sodium glucose co-transporter 2 (SGLT2) InhibitorsChok G Chan, Ralph Stewart
Pageof 8